Multidrug-resistant Acinetobacter baumannii strains carrying the blaOxA-23 and the blaGES-11 genes in a neonatology center in Tunisia

Microbial Pathogenesis

Volumn 74, Issue , 2014, Pages 20-24

  Charfi Kessis, Karama ^a,b   Mansour, Wejdene ^b   Ben Haj Khalifa, Anis ^c   Mastouri, Maha ^b   Nordmann, Patrice ^a,d   Aouni, Mahjoub ^b   Poirel, Laurent ^a,d  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c CHU Taher Sfar   (Tunisia)

^d UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; GES 11; Neonatology center; OXA 23; Tunisia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; ENZYME ACTIVITY; FEMALE; GENE LOCATION; HUMAN; INFANT; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TUNISIA; WARD; ACINETOBACTER INFECTION; CROSS INFECTION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAMASES; CHROMOSOMES, BACTERIAL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HOSPITALS; PLASMIDS; TUNISIA;

EID: 84930357623     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2014.07.003     Document Type: Article

References (26)

1. [1] Peleg, Y.A., Seifert, H., Paterson, D.L., Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:3 (2008), 538–582.
2. [2] Bonnin, R.A., Nordmann, P., Poirel, L., Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther 11:6 (2013), 571–583.
3. [3] Mansour, W., Poirel, L., Bettaieb, D., Bouallegue, O., Boujaafar, N., Nordmann, P., Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia. Microb Drug Resist 14:4 (2008), 289–292.
4. [4] Liakopoulos, A., Miriagou, V., Katsifas, E.A., Karagouni, A.D., Daikos, G.L., Tzouvelekis, L.S., et al. Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill, 17(11), 2012 PII=20117.
5. [5] Abdalhamid, B., Hassan, H., Itbaileh, A., Shorman, M., Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiol 37:1 (2014), 65–73.
6. [6] Kusradze, I., Diene, S.M., Goderdzishvili, M., Rolain, J.M., Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia. Int J Antimicrob Agents 38:2 (2011), 164–168.
7. [7] Poirel, L., Mansour, W., Bouallegue, O., Nordmann, P., Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob Agents Chemother 52:5 (2008), 1613–1617.
8. [8] Hammami, S., Ghozzi, R., Saidani, M., Ben Redjeb, S., Carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in Tunisia. Tunis Med 89:7 (2011), 638–643.
9. [9] Bonnin, R.A., Nordmann, P., Potron, A., Lecuyer, H., Zahar, J.H., Poirel, L., Carbapenem-hydrolyzing GES-type extended-spectrum ß-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 55:1 (2011), 349–354.
10. [10] Heritier, C., Poirel, L., Lambert, T., Nordmann, P., Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 49:8 (2005), 3198–3202.
11. [11] Poirel, L., Le Thomas, I., Naas, T., Karim, A., Nordmann, P., Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniea. Antimicrob Agents Chemother 44 (2000), 622–632.
12. [12] Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing (M100-S22). 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
13. [13] Bernabeu, S., Poirel, L., Nordmann, P., Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae. Diagn Microbiol Infect Dis 74:1 (2012), 88–90.
14. [14] Bonnin, R.A., Rotimi, V.O., Al Hubail, M., Gasiorowski, E., Al Sweih, N., Nordmann, P., et al. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob Agents Chemother 7:1 (2013), 183–188.
15. [15] Dubois, V., Poirel, L., Marie, C., Arpin, C., Nordmann, P., Quentin, C., Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6’-Ib’ gene cassettes in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46:3 (2002), 638–645.
16. [16] Pitout, J., Gregson, D.B., Poirel, L., McClure, J.A., Le, P., Church, D.L., Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J Antimicrob Chemother 43:7 (2005), 3129–3135.
17. [17] Poirel, L., Walsh, T.R., Cuvillier, V., Nordmann, P., Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbial Infect Dis 70 (2011), 119–123.
18. [18] Berçot, B., Poirel, L., Nordmann, P., Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1producers. Diagn Microbiol Infect Dis 71:4 (2011), 442–445.
19. [19] Bertini, A., Poirel, L., Mugnier, P.D., Villa, L., Nordmann, P., Carattoli, A., Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 54:10 (2010), 4168–4177.
20. [20] Kieser, T., Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12 (1984), 19–36.
21. [21] Heritier, C., Poirel, L., Aubert, D., Nordmann, P., Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob Agents Chemother 47 (2003), 268–273.
22. [22] Spiliopoulou, A., Jelastopulu, E., Vamvakopoulou, S., Bartzavali, C., Kolonitsiou, F., Anastassiou, E.D., et al. In vitro activity of tigecycline and colistin against A. baumannii clinical bloodstream isolates during an 8-year period. J Chemother, 14, 2014 1973947814Y0000000193.
23. [23] Moubareck, C., Bremont, S., Conroy, M.C., Courvalin, P., Lambert, T., GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother 53 (2009), 3579–3581.
24. [24] Al-Agamy, M.H., Khalaf, N.G., Tawfick, M.M., Shibl, A.M., El Kholy, A., Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22 (2014), 49–54.
25. [25] Bogaerts, P., Naas, T., El Garch, F., Cuzon, G., Deplano, A., Delaire, T., et al. GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother 54:11 (2010), 4872–4878.
26. [26] Bonnin, R.A., Cuzon, G., Poirel, L., Nordmann, P., Multidrug-resistant Acinetobacter baumannii clone, France. Emerg Infect Dis 19:5 (2013), 822–823.